Pricing Log in Create free account

Cadrenal Therapeutics, Inc. (CVKD) vs UNITY Biotechnology, Inc. (UNBX)

Cadrenal Therapeutics, Inc. and UNITY Biotechnology, Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and UNITY Biotechnology, Inc. are of similar size ($3.5M and $3.4M). Across the 8 metrics below, Cadrenal Therapeutics, Inc. leads on 4 and UNITY Biotechnology, Inc. on 4.

Valuation

Metric CVKD UNBX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.78 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (449.54%) (2,700.00%) (33.15%)
Free cash flow yield (320.05%) (2,174.64%) (25.50%)

Profitability

Metric CVKD UNBX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (275.16%) (231.27%) (56.36%)
Return on assets (199.59%) (61.66%) (48.04%)
Return on invested capital (427.54%) 0.00% 0.00%

Growth

Metric CVKD UNBX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 23.94% 42.96% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD UNBX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.73 1.95 4.72
Net debt to EBITDA 0.30 0.82 0.96

Dividend

Metric CVKD UNBX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CVKD UNBX Biotechnology median
Market cap 3.46m 3.44m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack